principles of treatment 2 Flashcards

1
Q

what are the different ways of treating cancer?

A
  • chemotherapy
  • monoclonal antibody therapy
  • targeted therapy
  • immunotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the standard therapy for diffuse B cell lymphoma and what can make it better?

A
  • CHOP

- it is significantly improved with the addition of rituximab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the different target spots for targeted therapy?

A
  1. growth factor kinase inhibitors
  2. apoptosis induction
  3. damage response inhibition
  4. epigenetic reprogramming
  5. telomerase inhibition
  6. redox modulation
  7. metabolic programming
  8. proteasome inhibition
  9. csc transdifferentiation
  10. immunomodulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

why are mot new targeted therapies for harm cancers?

A
  • blood is easier to access and target then tumours- its easier to take several blood tests that=n several biopsies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the genetic abnormality causing CML?

A

Philadelphia chromosome
translocation of chr9 and 22
resulting in bcrAbl fusion gene

this causes transformation of haematopoetic progenitor into malignant clone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how does imatinib treat CML?

A
  • binds to ATP binding site of BcrAbl and inactivates it
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are different ways that resistance to imatinib can arise?

A
  • Abl kinase domain mutations
  • amplification of BcrAbl
  • clonal evolution with less reliance on BcrAbl
  • drug efflux mechanism- imatinib is a pgp substrate, if pgp is increased it will reduce the bioavailability of imatinib
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are examples of second generation TKI?

A
  • nilotinib
  • dasatinib
  • bosutinib
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what percent of NSCLC patients have a mutation in EGFR kinase?

A

10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the target treatment for people that express EGFR kinase in NSCLC?

A

gefitinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what percentage of NSCLC patients have anapaestic lymphoma kinase mutations?

A

5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the treatment for ALK NSCLC?

A

crizotinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the treatment for melanoma px with braf mutation?

A

vemurafinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what type of drug is ibrutinib and who is it used for?

A

Bruton’s tyrosine kinase (BTK) inhibitor

relapsed/refractory CLL and mantle cell lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

which targeted therapy targets angiogenesis?

A

Bevacizumab

- blocks veg f receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what types of cancer is bevacizumab good for?

A
  • colon
  • lung
  • renal
17
Q

what percentage of breast cancer have mutated epidermal growth factor receptor 2- HER2?

A

25%

18
Q

what is the targeted therapy for her2 breast cancer patients

A

Herceptin (Traztuzumab) blocks competitively inhibits EGF from binding to EGFR